SDHB: Key Regulator of Cell Signaling Pathways and Inflammation

Target Name: SDHB

NCBI ID: G6390

SDHB

SDHB: Key Regulator of Cell Signaling Pathways and Inflammation

SDHB (Sulfur-Dioxide-Hydrogen-Borate) is a protein that is expressed in many tissues throughout the body. It is a key regulator of cell signaling pathways and is involved in the development and maintenance of tissues such as hair, nails, and bones. SDHB has also been shown to play a role in the regulation of inflammation and has potential as a drug target or biomarker.

SDHB is a protein that is made up of four subunits: alpha, beta, gamma, and delta. The alpha subunit is the most abundant and is responsible for the catalytic activity of SDHB. It is made up of a single polypeptide chain that contains 111 amino acids. The beta subunit is made up of a single polypeptide chain that contains 114 amino acids, while the gamma and delta subunits are both made up of two polypeptide chains that contain 108 and 95 amino acids, respectively.

SDHB is involved in a wide range of physiological processes in the body, including the regulation of cell signaling pathways, the development and maintenance of tissues, and the regulation of inflammation. One of the key functions of SDHB is its role in the regulation of cell signaling pathways. SDHB is a key regulator of the TGF-beta pathway, which is a well-known regulator of cell signaling pathways that is involved in the development and maintenance of tissues.

In addition to its role in cell signaling pathways, SDHB is also involved in the regulation of inflammation. One of the ways that SDHB contributes to inflammation regulation is by its role in the production of reactive oxygen species (ROS). ROS are highly reactive molecules that can cause damage to cells if they are not properly regulated. SDHB is involved in the production of ROS by working with the antioxidant NAD+, which is a critical molecule that helps to protect cells from damage caused by ROS.

SDHB has also been shown to play a role in the regulation of cell adhesion. Many tissues in the body are composed of cells that are adhered to one another, and the regulation of cell adhesion is critical for the development and maintenance of tissues. SDHB is involved in this process by its role in the production of adhesion molecules, which are important for cell-cell adhesion.

In addition to its role in cell signaling pathways, SDHB has also been shown to have potential as a drug target or biomarker. The ability of SDHB to regulate cell signaling pathways makes it an attractive target for drug development. Additionally, its role in the regulation of inflammation and cell adhesion also makes it a potential biomarker for a variety of diseases.

Overall, SDHB is a complex protein that is involved in a wide range of physiological processes in the body. Its role as a regulator of cell signaling pathways, inflammation, and cell adhesion makes it an attractive target for drug development and a potential biomarker for a variety of diseases. Further research is needed to fully understand the functions of SDHB and its potential as a drug target or biomarker.

Protein Name: Succinate Dehydrogenase Complex Iron Sulfur Subunit B

Functions: Iron-sulfur protein (IP) subunit of the succinate dehydrogenase complex (mitochondrial respiratory chain complex II), responsible for transferring electrons from succinate to ubiquinone (coenzyme Q)

The "SDHB Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SDHB comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets